Source content
FAA Guide for Aviation Medical Examiners · Version 10/28/2026 · page 831
Guide Official Revision Description Reason for Update
Version Date Number Of Change
SSRIs that may be
considered.
2023 05/31/2023 2. Medical Policy In Item 47. Psychiatric, Use
of Antidepressant
Medications, Updated SSRI-
Decision Path-I and SSRI-
Decision Path-II to add
bupropion (Wellbutrin –
Extended Release [EX] and
Sustained Release [SR]).
2023 05/31/2023 3. Medical Policy With the approval of
bupropion (Wellbutrin –
Extended Release [EX] and
Sustained Release [SR]),
revised language to remove
reference to “four” specific
SSRIs that may be
considered in
Pharmaceuticals,
Antidepressants
2023 05/31/2023 4. Medical Policy In Item 52. Color Vision,
Examination Techniques,
added table of acceptable
computerized color vision
tests with scoring criteria.
Approved for pilots, FAA
employee 2152 Series
ATCS, and contract tower
ATCS.
2023 05/31/2023 5. Administrative In Item 52. Color Vision,
Dispositions, under “An
applicant does not meet the
color vision standard if
testing reveals” section,
added hyperlink to score
criteria for approved
computerized tests.
2023 05/31/2023 6. Medical Policy In General Information,
Equipment Requirements,
revised to list three approved
computerized color vision
tests.
2023 05/31/2023 7. Medical Policy In Item 45. Lymphatics,
Leukemia, added new CACI
– Chronic Lymphocytic
Leukemia (CLL) Small
Shown as extracted from the FAA PDF, without paraphrasing. Tables and forms may lose their layout. Underlined references open the Guide location they name.
